Aadi Bioscience Analyst Ratings
Aadi Bioscience Analyst Ratings
While ratings are subjective and will change, the latest Aadi Bioscience (AADI) rating was a reiterated with a price target of $0.00 to $45.00. The current price Aadi Bioscience (AADI) is trading at is $5.44, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/10/2023 | 727.21% | HC Wainwright & Co. | → $45 | Reiterates | Buy → Buy |
| 06/08/2023 | 727.21% | HC Wainwright & Co. | → $45 | Reiterates | Buy → Buy |
| 05/17/2023 | 727.21% | HC Wainwright & Co. | → $45 | Reiterates | Buy → Buy |
| 03/29/2023 | 727.21% | HC Wainwright & Co. | $48 → $45 | Maintains | Buy |
| 04/11/2022 | 782.35% | HC Wainwright & Co. | $49 → $48 | Maintains | Buy |
| 01/11/2022 | 727.21% | Jefferies | → $45 | Initiates Coverage On | → Buy |
| 11/24/2021 | 800.74% | HC Wainwright & Co. | $47 → $49 | Maintains | Buy |
| 10/01/2021 | — | Cowen & Co. | Initiates Coverage On | → Outperform | |
| 09/14/2021 | 837.5% | Ladenburg Thalmann | → $51 | Initiates Coverage On | → Buy |
| 09/08/2021 | 727.21% | Piper Sandler | → $45 | Initiates Coverage On | → Overweight |
| 08/30/2021 | 763.97% | HC Wainwright & Co. | $22 → $47 | Maintains | Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 08/10/2023 | 727.21% | HC Wainwright & Co. | → 45 美元 | 重申 | 購買 → 購買 |
| 06/08/2023 | 727.21% | HC Wainwright & Co. | → 45 美元 | 重申 | 購買 → 購買 |
| 05/17/2023 | 727.21% | HC Wainwright & Co. | → 45 美元 | 重申 | 購買 → 購買 |
| 03/29/2023 | 727.21% | HC Wainwright & Co. | 48 美元 → 45 美元 | 維護 | 購買 |
| 2022 年 11 月 4 日 | 782.35% | HC Wainwright & Co. | 49 美元 → 48 美元 | 維護 | 購買 |
| 01/11/2022 | 727.21% | 傑富瑞 | → 45 美元 | 啓動覆蓋開啓 | → 購買 |
| 11/24/2021 | 800.74% | HC Wainwright & Co. | 47 美元 → 49 美元 | 維護 | 購買 |
| 2021 年 1 月 10 日 | — | Cowen & Co. | 啓動覆蓋開啓 | → 跑贏大盤 | |
| 2021 年 9 月 14 日 | 837.5% | 拉登堡塔爾曼 | → 51 美元 | 啓動覆蓋開啓 | → 購買 |
| 09/08/2021 | 727.21% | 派珀·桑德勒 | → 45 美元 | 啓動覆蓋開啓 | → 超重 |
| 2021 年 8 月 30 日 | 763.97% | HC Wainwright & Co. | 22 美元 → 47 美元 | 維護 | 購買 |
What is the target price for Aadi Bioscience (AADI)?
Aadi Bioscience（AADI）的目標價格是多少？
The latest price target for Aadi Bioscience (NASDAQ: AADI) was reported by HC Wainwright & Co. on August 10, 2023. The analyst firm set a price target for $45.00 expecting AADI to rise to within 12 months (a possible 727.21% upside). 4 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 於2023年8月10日公佈了Aadi Bioscience（納斯達克股票代碼：AADI）的最新目標股價。這家分析公司將目標股價定爲45.00美元，預計AADI將在12個月內升至45.00美元（可能上漲727.21％）。去年有4家分析公司公佈了評級。
What is the most recent analyst rating for Aadi Bioscience (AADI)?
分析師對Aadi Bioscience（AADI）的最新評級是多少？
The latest analyst rating for Aadi Bioscience (NASDAQ: AADI) was provided by HC Wainwright & Co., and Aadi Bioscience reiterated their buy rating.
Aadi Bioscience（納斯達克股票代碼：AADI）的最新分析師評級由HC Wainwright & Co. 提供，Aadi Bioscience重申了他們的買入評級。
When is the next analyst rating going to be posted or updated for Aadi Bioscience (AADI)?
Aadi Bioscience（AADI）的下一個分析師評級何時公佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aadi Bioscience, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aadi Bioscience was filed on August 10, 2023 so you should expect the next rating to be made available sometime around August 10, 2024.
分析師在進行了廣泛的研究（包括瀏覽公開財務報表、與Aadi Bioscience的高管和客戶交談以及聽取業績電話會議）後得出股票評級。大多數分析師每三個月進行一次評級，因此每家公司每年應該獲得4個評級。Aadi Bioscience的最後一次評級是在2023年8月10日提交的，因此你應該預計下一個評級將在2024年8月10日左右公佈。
Is the Analyst Rating Aadi Bioscience (AADI) correct?
分析師對Aadi Bioscience (AADI) 的評級是否正確？
While ratings are subjective and will change, the latest Aadi Bioscience (AADI) rating was a reiterated with a price target of $0.00 to $45.00. The current price Aadi Bioscience (AADI) is trading at is $5.44, which is within the analyst's predicted range.
儘管評級是主觀的，將會發生變化，但最新的Aadi Bioscience（AADI）評級得到了重申，目標股價爲0.00美元至45.00美元。Aadi Bioscience（AADI）目前的交易價格爲5.44美元，在分析師的預測區間內。